Kevin A. Hay
Occupational Cancer Research Centre(CA)
Publications by Year
Research Areas
CAR-T cell therapy research, Lymphoma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research, Chronic Lymphocytic Leukemia Research, Biosimilars and Bioanalytical Methods
Most-Cited Works
- → Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells(2017)1,320 cited
- → Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy(2017)1,083 cited
- → Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor–Modified T Cells After Failure of Ibrutinib(2017)651 cited
- → Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy(2017)547 cited
- → Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy(2019)394 cited
- → The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells(2019)327 cited
- → Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure(2020)314 cited
- → Cytokine release syndrome and neurotoxicity afterCD19 chimeric antigen receptor‐modified (CAR‐) T cell therapy(2018)186 cited
- → Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes(2020)184 cited
- → High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy(2019)174 cited